NRG1 and neoplasm: Traditionally, paracrine growth factors were thought to be produced by cancer or neighboring stromal cells, but this study highlights tumor-infiltrating inflammatory cells as a dominant source of NRG1, emphasizing the therapeutic potential of targeting immune cell-derived signaling pathways.